Literature DB >> 16629592

Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection.

Xiangzhong Li1, Fang Fang, Yunlong Song, Hongli Yan, Haiyan Chang, Shuhan Sun, Ze Chen.   

Abstract

Neuraminidase (NA) is one of the surface glycoproteins of influenza virus. The immune response induced by NA DNA in the mouse model has been proved, in our previous study, to be able to provide an adequate protection against the challenge with a homologous virus and a crossprotection against the challenge with a heterologous virus of the same subtype. In this paper, a series of NA plasmid truncates, with the nucleotides at the 5'- or 3'-terminal of A/PR/8/34 (H1N1) NA deleted serially, were constructed by PCR. BALB/c mice were immunized with the plasmid truncates and challenged with homologous virus at a lethal dosage. The essential sequence of NA DNA to provide protection against the influenza virus was explored by observing the survival rates, serum anti-NA antibody titers, and lung virus titers of the mice. The result showed that, along with the increasing number of nucleotides deleted serially at the 5'- or 3'-terminal of NA DNA, the antibody titer induced by NA DNA decreased. NA DNA lost its protection against the influenza virus when 60 nucleotides (or 20 amino acids) at the 5'-terminal or 66 nucleotides (or 22 amino acids) at the 3'-terminal were deleted. The nt58-1299 of NA DNA may play an important role in protection against influenza virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629592     DOI: 10.1089/dna.2006.25.197

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  7 in total

Review 1.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

2.  H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.

Authors:  Surender Khurana; Jian Wu; Nitin Verma; Swati Verma; Ramadevi Raghunandan; Jody Manischewitz; Lisa R King; Eloi Kpamegan; Steven Pincus; Gale Smith; Gregory Glenn; Hana Golding
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

3.  Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.

Authors:  Fu-Shi Quan; Min-Chul Kim; Byeong-Jae Lee; Jae-Min Song; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2012-06-02       Impact factor: 3.616

4.  Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase.

Authors:  Ambarnil Ghosh; Ashesh Nandy; Papiya Nandy
Journal:  BMC Struct Biol       Date:  2010-02-22

Review 5.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

6.  Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.

Authors:  Zekun Liu; Junpeng Zhao; Weichen Li; Li Shen; Shengbo Huang; Jingjing Tang; Jie Duan; Fang Fang; Yuelong Huang; Haiyan Chang; Ze Chen; Ran Zhang
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

7.  Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.

Authors:  Jianjun Chen; Fenghua Zhang; Fang Fang; Haiyan Chang; Ze Chen
Journal:  BMC Infect Dis       Date:  2007-10-16       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.